SLC5A2 and type 2 diabetes mellitus: The present study showed that T2DM patients treated with SGLT2 inhibitors displayed positive effects on left ventricular remodelling due to a reduction in LVM, and LV longitudinal function assessed by speckle tracking echocardiography.